JESSIE BAUDNER: Open Payments
NPI 1881930824 · WATERFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,735 in 71 payments from 13 companies in 2025. Trend: 2023 $1,161 · 2024 $2,143 · 2025 $1,735
Food & beverage: $1,646Education: $89
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 16 | $357 |
| ABBVIE INC. | 14 | $269 |
| QOL Medical, LLC | 5 | $235 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $227 |
| Janssen Biotech, Inc. | 4 | $157 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $99 |
| Madrigal Pharmaceuticals | 3 | $90 |
| Ardelyx, Inc. | 5 | $89 |
| Gilead Sciences, Inc. | 3 | $74 |
| EVOKE PHARMA, INC. | 3 | $51 |
Products named: VOQUEZNA, Sucraid, XIFAXAN, TREMFYA, SKYRIZI, REZDIFFRA, IBSRELA, LINZESS.
Industry payments across CT — which companies pay providers there.
